Addressing Viability and Commercial Challenges of Manufacturing Large Biologics
Date: 15 December 2021
Speaker: Jonathan Kingsbury, Benjamin Neunstoecklin
Jonathan Kingsbury | Head of Developability & pre-formulation, Sanofi
Benjamin Neunstoecklin | Lead Process Engineer, MSAT Biotech, Bayer, Switzerland
Jonathan Kingsbury | Head of Developability & pre-formulation, Sanofi
Benjamin Neunstoecklin | Lead Process Engineer, MSAT Biotech, Bayer, Switzerland
Content:
Here's the agenda for this webinar:
- Developability to Ensure Streamlined Manufacturing
- A Technical End-to-End Project Review to Ensure Commercial Viability of Biologic Products
- Developability to Ensure Streamlined Manufacturing
- A Technical End-to-End Project Review to Ensure Commercial Viability of Biologic Products
IPEC-China Excipients Regulatory Communication Part III: Practice Sharing on Pharmaceutical Excipient Registration and Change Management
Date: 14 December 2021
Speaker: Cissy Suming WANG, Martin TAO, Florence XU
Cissy Suming WANG | IPEC CHINA, Ashland (China) Holdings
Martin TAO | IPEC CHINA, IFF
Florence XU | IPEC CHINA, Shanghai Colorcon Coating Tech
Cissy Suming WANG | IPEC CHINA, Ashland (China) Holdings
Martin TAO | IPEC CHINA, IFF
Florence XU | IPEC CHINA, Shanghai Colorcon Coating Tech
Content:
Here's the agenda for this webinar:
- IPEC-China Excipients Regulatory Communication Conferences Introduction
- Excipients Change Management in China DMF Framework and its Technical Requirements
- Practice on Registration of Pharmaceutical Excipients in China
- IPEC-China Excipients Regulatory Communication Conferences Introduction
- Excipients Change Management in China DMF Framework and its Technical Requirements
- Practice on Registration of Pharmaceutical Excipients in China
European Regulatory Outlook
Date: 13 December 2021
Speaker: Adrian van den Hoven
Director General, Medicines for Europe
Director General, Medicines for Europe
Content:
Join Director General of Medicines for Europe, Adrian van den Hoven for this keynote session, exploring the European regulatory outlook for pharma.
Here's the agenda for this webinar:
- The Pharmaceutical Industry as a Key Asset to the EU Economy
- Pharmaceutical Strategy for Europe
- Supporting a competitive & Innovative EU Pharmaceutical Industry
- Exploring initiatives on Manufacturing Competitiveness and Regulatory Efficiency
- Pharma Driving Sustainable post-pandemic growth
- Considerations for the Future EU Pharmaceutical Strategy
Here's the agenda for this webinar:
- The Pharmaceutical Industry as a Key Asset to the EU Economy
- Pharmaceutical Strategy for Europe
- Supporting a competitive & Innovative EU Pharmaceutical Industry
- Exploring initiatives on Manufacturing Competitiveness and Regulatory Efficiency
- Pharma Driving Sustainable post-pandemic growth
- Considerations for the Future EU Pharmaceutical Strategy
Future Developments and Practices for mAbs and other Complex Molecules
Date: 10 December 2021
Speaker: Ross Crockett
Process Engineer II, Process Technical Development, Clinical Supply Centre and Digital Sciences, Genentech
Process Engineer II, Process Technical Development, Clinical Supply Centre and Digital Sciences, Genentech
Content:
Here's the agenda for this webinar:
- Approaches for the Design and Selection of Single-Use Assemblies in a Clinical Drug Substance Manufacturing Facility
- Applying data-driven models in biopharmaceutical manufacturing to improve real-time decision-making
- Approaches for the Design and Selection of Single-Use Assemblies in a Clinical Drug Substance Manufacturing Facility
- Applying data-driven models in biopharmaceutical manufacturing to improve real-time decision-making
India Pharma Innovation Landscape
Date: 09 December 2021
Speaker: Dinesh Dua, Sriram Shrinivasan
Dinesh Dua | Executive Director on Board, Nectar Lifesciences Limited
Sriram Shrinivasan | Global Generics Leader and India Health & Lifesciences Leade
Dinesh Dua | Executive Director on Board, Nectar Lifesciences Limited
Sriram Shrinivasan | Global Generics Leader and India Health & Lifesciences Leade
Content:
India, with a population of almost 1.4 billion, is becoming ever more vocal about access to good quality healthcare, which will have a huge impact on the fortunes of the country’s pharmaceutical sector going forward. While India is the largest global producer of generic drugs, there is also a rising interest in drug discovery and development for innovator products, and this session will examine India's potential to become celebrated as an innovator market.
Here's the agenda for this webinar:
- India Pharma Innovation Landscape
- India Global Power Horse of Pharma Formulations & Atamnirbharta in intermediates, API's &KSM's
Here's the agenda for this webinar:
- India Pharma Innovation Landscape
- India Global Power Horse of Pharma Formulations & Atamnirbharta in intermediates, API's &KSM's
Play
Pharma Sources Insight June 2024: Globalization on the Go
